| General Info | Portfolio Holdings | Fund Performance | Fund Management Fees and Expenses | Minimum Investments | Open an Account Now |
Ticker Symbol: MIOFX
Performance Data |
Total Annual Operating Expenses3 | |||||
| As of end of month August | ||||||
| Calendar YTD | 1 Year | 3 Year | 5 Year | Inception1 | ||
| Marsico International Opportunities Fund |
-20.10% | -10.67% | 11.01% | 14.67% | 7.22% | 1.38% |
| MSCI EAFE Index2 | -17.31% | -14.41% | 8.08% | 13.86% | 3.25% | -- |
Performance data quoted represents past performance. Investment return and principal will fluctuate, so that shares, when redeemed, may be worth more or less than their original cost. Past performance is no guarantee of future results. Current performance may be lower or higher than the performance information quoted. A fund's performance, especially for short time periods, should not be the sole factor in making an investment decision. For performance comparison as of most recent quarter-end, click here. A redemption fee of 2.00% may be imposed on redemptions or exchanges of Fund shares you have owned for 30 days or less. Please see the prospectus for more information. Total returns are based on net change in NAV assuming reinvestment of distributions. For the period prior to September 30, 2004, the performance returns for the Fund reflect a fee waiver in effect; in absence of such a waiver, the returns would have been reduced. For the period beginning October 1, 2004 through December 2005, performance returns for the Fund would be higher but for the reimbursement of fees waived previously. | ||||||
COMPARATIVE RANKING AND RATINGS
|
|
||||||||||||||||||||||||||||||||||||||||||||||
Growth of 10K |
| 1Average Annual Total Return from fund's inception, 6/30/00 2The Morgan Stanley Capital International EAFE Index tracks the stocks of about 1,000 companies in Europe, Australasia, and the Far East (EAFE). You cannot invest directly in an index. 3The Total Annual Operating Expenses are reflective of the information disclosed in the Fund's current prospectus. Please see the prospectus for more information. |






